Drug Enforcement Administration – Federal Register Recent Federal Regulation Documents

Results 1 - 50 of 4,445
Importer of Controlled Substances Application: Leading Pharma LLC
Document Number: 2024-29997
Type: Notice
Date: 2024-12-18
Agency: Drug Enforcement Administration, Department of Justice
Leading Pharma LLC to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Established Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2025
Document Number: 2024-30023
Type: Notice
Date: 2024-12-17
Agency: Drug Enforcement Administration, Department of Justice
This final order establishes the initial 2025 aggregate production quotas for controlled substances in schedules I and II of the Controlled Substances Act and the assessment of annual needs for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine.
Final Adjusted Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2024
Document Number: 2024-30019
Type: Notice
Date: 2024-12-17
Agency: Drug Enforcement Administration, Department of Justice
This final order establishes the final adjusted 2024 aggregate production quotas for controlled substances in schedules I and II of the Controlled Substances Act and the assessment of annual needs for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine.
Importer of Controlled Substances Application: Groff NA Hemplex LLC
Document Number: 2024-29343
Type: Notice
Date: 2024-12-13
Agency: Drug Enforcement Administration, Department of Justice
Groff NA Hemplex LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: National Center for Natural Products Research
Document Number: 2024-29341
Type: Notice
Date: 2024-12-13
Agency: Drug Enforcement Administration, Department of Justice
National Center for Natural Products Research has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Noramco
Document Number: 2024-28728
Type: Notice
Date: 2024-12-06
Agency: Drug Enforcement Administration, Department of Justice
Noramco has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Navinta LLC
Document Number: 2024-28719
Type: Notice
Date: 2024-12-06
Agency: Drug Enforcement Administration, Department of Justice
Navinta LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Organic Standards Solutions International, LLC
Document Number: 2024-28717
Type: Notice
Date: 2024-12-06
Agency: Drug Enforcement Administration, Department of Justice
Organic Standards Solutions International, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Kinetochem LLC
Document Number: 2024-28715
Type: Notice
Date: 2024-12-06
Agency: Drug Enforcement Administration, Department of Justice
Kinetochem LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Curia Wisconsin, Inc.
Document Number: 2024-28063
Type: Notice
Date: 2024-11-29
Agency: Drug Enforcement Administration, Department of Justice
Curia Wisconsin, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Cambrex Charles City
Document Number: 2024-28064
Type: Notice
Date: 2024-11-29
Agency: Drug Enforcement Administration, Department of Justice
Cambrex Charles City has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Organix Chemistry Solutions, LLC
Document Number: 2024-27674
Type: Notice
Date: 2024-11-26
Agency: Drug Enforcement Administration, Department of Justice
Organix Chemistry Solutions, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Experic LLC
Document Number: 2024-27673
Type: Notice
Date: 2024-11-26
Agency: Drug Enforcement Administration, Department of Justice
Experic LLC to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Cayman Chemical Company
Document Number: 2024-27670
Type: Notice
Date: 2024-11-26
Agency: Drug Enforcement Administration, Department of Justice
Cayman Chemical Company has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Isosciences, LLC
Document Number: 2024-27693
Type: Notice
Date: 2024-11-26
Agency: Drug Enforcement Administration, Department of Justice
Isosciences, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: National Center for Natural Products Research
Document Number: 2024-27694
Type: Notice
Date: 2024-11-26
Agency: Drug Enforcement Administration, Department of Justice
National Center for Natural Products Research has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Third Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications
Document Number: 2024-27018
Type: Rule
Date: 2024-11-19
Agency: Drug Enforcement Administration, Department of Justice, Department of Health and Human Services
The Drug Enforcement Administration (DEA) in concert with the Department of Health and Human Services (HHS) is issuing a third extension of telemedicine flexibilities for the prescribing of controlled medications, through December 31, 2025.
Possible Control of Phenethyl Bromide as a List I Chemical
Document Number: 2024-24616
Type: Proposed Rule
Date: 2024-10-28
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) finds that phenethyl bromide is used in the illicit manufacture of the controlled substance fentanyl, as well as fentanyl analogues and fentanyl-related substances, and is important to the manufacture of these substances because it is often used in synthetic pathways to illicitly manufacture fentanyl, fentanyl analogues, and fentanyl-related substances. Prior to proposing to list phenethyl bromide as a list I chemical under the Controlled Substances Act, DEA is soliciting information on the current uses of phenethyl bromide (other than for the synthesis of fentanyl) in order to properly determine the effect such a proposed action would have on legitimate industry.
Schedules of Controlled Substances: Placement of Butonitazene, Flunitazene, and Metodesnitazene Substances in Schedule I
Document Number: 2024-24635
Type: Rule
Date: 2024-10-25
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration places butonitazene, flunitazene, and metodesnitazene including their isomers, esters, ethers, salts and salts of isomers, esters and ethers in schedule I of the Controlled Substances Act. The regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess), or propose to handle these three specific controlled substances will continue to apply as a result of this action.
BRX Pharmacy; Decision and Order
Document Number: 2024-24564
Type: Notice
Date: 2024-10-23
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Halo Pharmaceutical Inc.
Document Number: 2024-24560
Type: Notice
Date: 2024-10-23
Agency: Drug Enforcement Administration, Department of Justice
Halo Pharmaceutical Inc. to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Mylan Technologies Inc
Document Number: 2024-24557
Type: Notice
Date: 2024-10-23
Agency: Drug Enforcement Administration, Department of Justice
Mylan Technologies Inc to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
David Carlos Rodriguez, M.D.; Decision and Order
Document Number: 2024-24575
Type: Notice
Date: 2024-10-23
Agency: Drug Enforcement Administration, Department of Justice
Itani Family Pharmacy, PLC; Decision And Order
Document Number: 2024-24572
Type: Notice
Date: 2024-10-23
Agency: Drug Enforcement Administration, Department of Justice
Dale Fitzpatrick, M.D.; Decision and Order
Document Number: 2024-24570
Type: Notice
Date: 2024-10-23
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Irvine Labs, Inc.
Document Number: 2024-24554
Type: Notice
Date: 2024-10-23
Agency: Drug Enforcement Administration, Department of Justice
Irvine Labs, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Irvine Labs, Inc.
Document Number: 2024-24553
Type: Notice
Date: 2024-10-23
Agency: Drug Enforcement Administration, Department of Justice
Irvine Labs, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Schedules of Controlled Substances: Placement of Ethylphenidate in Schedule I
Document Number: 2024-24083
Type: Rule
Date: 2024-10-22
Agency: Drug Enforcement Administration, Department of Justice
With the issuance of this final rule, the Drug Enforcement Administration places ethylphenidate (chemical name: ethyl 2-phenyl-2- (piperidin-2-yl)acetate), including its salts, isomers, and salts of isomers, in schedule I of the Controlled Substances Act. This action is being taken, in part, to enable the United States to meet its obligations under the 1971 Convention on Psychotropic Substances. When finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle ethylphenidate.
Neeraj B. Shah, M.D.; Decision and Order
Document Number: 2024-24189
Type: Notice
Date: 2024-10-21
Agency: Drug Enforcement Administration, Department of Justice
Janet S. Pettyjohn, D.O.; Decision and Order
Document Number: 2024-23511
Type: Notice
Date: 2024-10-11
Agency: Drug Enforcement Administration, Department of Justice
William J. Mack, M.D.; Decision and Order
Document Number: 2024-23515
Type: Notice
Date: 2024-10-11
Agency: Drug Enforcement Administration, Department of Justice
Robert P. Hansen, M.D.; Decision and Order
Document Number: 2024-23514
Type: Notice
Date: 2024-10-11
Agency: Drug Enforcement Administration, Department of Justice
Michael Berman, D.O.; Decision and Order
Document Number: 2024-23513
Type: Notice
Date: 2024-10-11
Agency: Drug Enforcement Administration, Department of Justice
Midtown Specialty RX; Decision and Order
Document Number: 2024-23482
Type: Notice
Date: 2024-10-10
Agency: Drug Enforcement Administration, Department of Justice
Halowells Pharmacy; Decision and Order
Document Number: 2024-23495
Type: Notice
Date: 2024-10-10
Agency: Drug Enforcement Administration, Department of Justice
Salman Akbar, M.D.; Decision and Order
Document Number: 2024-23504
Type: Notice
Date: 2024-10-10
Agency: Drug Enforcement Administration, Department of Justice
Merry Alice Troupe, N.P.; Decision and Order
Document Number: 2024-23170
Type: Notice
Date: 2024-10-08
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Fresenius Kabi USA, LLC
Document Number: 2024-22450
Type: Notice
Date: 2024-10-01
Agency: Drug Enforcement Administration, Department of Justice
Fresenius Kabi USA, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Curia Wisconsin, Inc.
Document Number: 2024-22446
Type: Notice
Date: 2024-10-01
Agency: Drug Enforcement Administration, Department of Justice
Curia Wisconsin, Inc., has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Michael Fletcher, M.D.; Decision and Order
Document Number: 2024-22205
Type: Notice
Date: 2024-09-27
Agency: Drug Enforcement Administration, Department of Justice
Lawrence Rudolph, D.M.D.; Decision and Order
Document Number: 2024-22204
Type: Notice
Date: 2024-09-27
Agency: Drug Enforcement Administration, Department of Justice
Charles Sangmoah, P.A.; Decision and Order
Document Number: 2024-22202
Type: Notice
Date: 2024-09-27
Agency: Drug Enforcement Administration, Department of Justice
Theodore S. Wright Jr., M.D.; Decision and Order
Document Number: 2024-22200
Type: Notice
Date: 2024-09-27
Agency: Drug Enforcement Administration, Department of Justice
Adam L. Larson, M.D.; Decision and Order
Document Number: 2024-22191
Type: Notice
Date: 2024-09-27
Agency: Drug Enforcement Administration, Department of Justice
Wagner Gervais, P.A.; Decision and Order
Document Number: 2024-22190
Type: Notice
Date: 2024-09-27
Agency: Drug Enforcement Administration, Department of Justice
Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2025
Document Number: 2024-21962
Type: Notice
Date: 2024-09-25
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) proposes to establish the 2025 aggregate production quotas for controlled substances in schedules I and II of the Controlled Substances Act (CSA) and the assessment of annual needs for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine.
Proposed Adjustments to the Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2024
Document Number: 2024-21960
Type: Notice
Date: 2024-09-25
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration proposes to adjust the 2024 aggregate production quotas for several controlled substances in schedules I and II of the Controlled Substances Act. Additionally, as DEA announced in an April 29, 2024 letter to DEA-registered manufacturers, procurement quotas for commercial manufacturing of a schedule II controlled substance will be calculated on a semi-annual basis, except for injectable drug products containing schedule II controlled substances, which will be calculated on an annual basis.
Importer of Controlled Substances Application: Curium US LLC
Document Number: 2024-21850
Type: Notice
Date: 2024-09-25
Agency: Drug Enforcement Administration, Department of Justice
Curium US LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Chemtos, LLC
Document Number: 2024-21062
Type: Notice
Date: 2024-09-17
Agency: Drug Enforcement Administration, Department of Justice
Chemtos, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Eli-Elsohly Laboratories
Document Number: 2024-21060
Type: Notice
Date: 2024-09-17
Agency: Drug Enforcement Administration, Department of Justice
Eli-Elsohly Laboratories has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.